PeptideAgentAsk PeptideAgent
Full catalog/CJC-1295 / Ipamorelin
FORMULATION / BLEND

CJC-1295 / Ipamorelin

A two-ingredient combination record. Evidence for either component is not automatically evidence for the combined formulation.

Record boundary
Type
Combination
Category
Growth Hormone
Status
Editorial review pending
On this page

01 / CLASSIFICATION

The formulation is not the scientific entity.

CJC-1295 / Ipamorelin remains a distinct record because route, ingredient verification, compounding, and combination context can change which evidence and status statements apply.

Coverage is not endorsement

This page confirms that the item exists in the coverage graph. It does not recommend use or repeat commercial benefit claims.

02 / COMPONENTS

Linked to ingredient-level records.

ComponentCJC-1295Peptide analog
ComponentIpamorelinSynthetic peptide

The named components are explicit. That does not establish formulation equivalence, dosing, safety, or outcomes.

03 / SOURCES

Inspect the record trail.

01
COVERAGE SOURCEBB Health+ peptide directory

Source inventory reviewed August 8, 2026

04 / REVIEW BOUNDARY

What is still intentionally unresolved.

Evidence

No evidence score is shown until human and preclinical sources are reviewed separately.

Status

No approval, compounding, or anti-doping statement is inherited from a related ingredient without review.